Latest Headlines

  1. MKS Announces New Ophir® NanoScan™ Scanning Slit Laser Beam Profilers for Sub-Micron Measurement of Tunable Lasers and Mid IR Lasers
    8/15/2018

    MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of technologies that enable advanced processes and improve productivity, has announced new additions to the Ophir® NanoScan™ 2s line of high power, scanning slit laser beam profilers. NanoScan products are NIST-calibrated profilers that instantly measure beam position and size with sub-micron precision for CW and kilohertz pulsed lasers. NanoScan profilers offer a choice of silicon, germanium, or pyroelectric detectors, which allows profiling lasers of any wavelength, from UV to far infrared, to 100μm and beyond.

  2. FAU Researchers Develop Procedure For Touch-Free Monitoring Of Heart Sounds
    8/13/2018

    In conjunction with researchers at Brandenburg University of Technology (BTU) in Cottbus and the Department of Palliative Medicine at Universitätsklinikum Erlangen, electronic engineers at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) have developed a procedure for reliably detecting and diagnosing heart sounds using radar.

  3. Amcor To Acquire Packaging Rival Bemis For $5.26B
    8/6/2018

    Australia’s Amcor Ltd. agreed to acquire U.S. competitor Bemis Co. in an all-stock deal valued at $5.26B to expand sales of plastic packaging in the Americas.

  4. Breast Cancer Device Receives FDA Approval
    8/1/2018

    Endomag, the surgical guidance company, announced that it has received premarket approval (PMA) from the U.S. Food and Drug Administration (FDA) for Magtrace, the first non-radioactive, dual-tracer for lymphatic mapping in patients with breast cancer undergoing a mastectomy.

  5. FDA Oks Medtronic’s Implantable System For Remodulin To Treat Pulmonary Arterial Hypertension
    7/31/2018

    Medtronic plc (NYSE:MDT) has received U.S. Food and Drug Administration (FDA) approval for the Implantable System for Remodulin® (ISR) to treat patients with pulmonary arterial hypertension (PAH).

  6. FDA Unveils FY 2019 GDUFA, BsUFA And MDUFA Fees
    7/30/2018

    With the new five-year user fee programs now in their second year, generic drug and medical device companies are seeing increases in user fees while biosimilar companies are seeing decreases.

  7. Phillips-Medisize Enhances Integrated Connected Health Platform
    7/26/2018

    Phillips-Medisize, a Molex company, announced the release of its third generation connected health platform, a service offering for its pharma and drug delivery device clients. The platform builds on the success of the company’s first connected health solutions, including the first FDA-approved combination product for medication adherence, and incorporates more than a decade of experience in developing connected health solutions.

  8. FDA Clears LifeSignals’ Vital Sign Wireless Monitoring Patch And ECG Application
    7/26/2018

    LifeSignals announced recently that it received FDA clearance for its wireless LP1100 Life Signal Patch for enabling the next generation of wearable, healthcare monitoring devices. It is built on two solid technology foundations to provide unprecedented attributes unachieved by another ECG patch product to date.

  9. FDA Clears Healthy.io's Smartphone-Enabled Urinalysis Kit
    7/25/2018

    Approval Helps Healthy.io Usher in Era of Medical Selfie, Leveraging Embedded Smartphone Cameras to Improve Patient Adherence and Outcomes and Curb Healthcare Expenditures.

  10. MED-EL Hearing Implant System Gains FDA De Novo Clearance
    7/24/2018

    MED-EL USA announced recently that the U.S. Food and Drug Administration (FDA) has granted de novo clearance for the BONEBRIDGE bone conduction hearing implant system for individuals 12 years and older who have been diagnosed with conductive hearing loss, mixed hearing loss, or single-sided deafness.